ACM Research (NASDAQ:ACMR) Stock, Quote.Headers.trade-ideas

ACM Research

ACM Research Inc is a United-based company. It is engaged in developing, manufacturing, and selling single-wafer wet cleaning equipment, which is used by semiconductor manufacturers in numerous manufacturing steps to remove particles, contaminants, and other random defects to improve product yield, in fabricating integrated circuits, or chips. The company offers space alternated phase shift which employs alternating phases of megasonic waves to deliver megasonic energy to flat and patterned wafer surfaces on a microscopic level; and Timely Energized Bubble Oscillation technology which provides effective, damage-free cleaning for both conventional two and three-dimensional patterned wafers at process nodes.

Small Cap

Markets

ACMR

AFRM

DELL

Nuveen Arizona Dividend Advantage Municipal Funds 3

SMCI

STRL

Will Russia Finally Retaliate Outside Of The Ukraine? 



Protecting Your Portfolio In The Event Russia Retaliates Against The U.S. For The Sevastopol Attack

Trading Ideas

COIN

CSCO

MSTR

NVDA

America&#39;s Next Financial Crisis

In our last post (&#34;America&#39;s Next Financial Crisis&#34;), we wrote about how one economist estimates that America&#39;s next financial crisis could lead to a 27% decline in living standards. 

From The Viewpoint Of Calamity--Investing With The Next Financial Crisis In Mind

Aon - logo

News

Intraday Update

Movers

ACCD

ACON

AILE

AIRE

ALSN

APPF

ARCB

ATXI

BACK

BDRX

CGEM

CSSE

DXCM

ELWS

EXPO

FCUV

FRGT

GOOG

GOOGL

ICLK

INTC

KNSL

KTOS

Kintara Therapeutics, Inc. - Common Stock

KTRA

Eaton Vance Massachusetts Municipal Income Trust

NIVF

NUWE

NWGL

ODFL

PCSA

PEGY

RERE

ROKU

SAIA

SBFM

SGBX

SKIL

SLCA

SNAP

TEAM

TNET

TVGN

VINC

WORX

ZVSA

Why Aon Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

ACM Research, Inc. - Class A Common Stock

ACM Research Inc

RBRK

Rubrik Expands Cyber Recovery And Incident Response Capabilities For Nutanix AHV, Offering Enhanced Testing, Recovery Validation, And Forensic Investigation Tools

Loop Capital analyst Alton Stump reiterates Domino's Pizza (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>) with a Hold and maintains $419 price target.

Price Target

Reiteration

Analyst Ratings

Loop Capital Reiterates Hold on Domino's Pizza, Maintains $419 Price Target

Crypto
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40955750/bitcoins-correction-ends-but-it-has-to-break-this-target-to-surge-to-70k-10x-research">Bitcoin&#8217;s Correction Ends, But It Has To Break This Target To Surge To $70K: 10x Research</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40954186/fbi-arrests-2-people-allegedly-behind-230m-bitcoin-heist-laundered-proceeds-were-spent-on-">FBI Arrests 2 People Allegedly Behind $230M Bitcoin Heist: Laundered Proceeds Were Spent On Globetrotting, High-End Wheels, And Designer Handbags</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40951537/solana-based-memecoins-spike-dogwifhat-bonk-outshine-dogecoin-shiba-inu-in-24-hour-gains">Solana-Based Memecoins Spike — Dogwifhat, Bonk Outshine Dogecoin, Shiba Inu In 24-Hour Gains</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40951091/bitcoin-ethereum-dogecoin-move-higher-as-aggressive-rate-cut-by-fed-fuels-crypto-demand-to">Bitcoin, Ethereum, Dogecoin Move Higher As Aggressive Rate Cut By Fed Fuels Crypto Demand: Top Trader&#8217;s Bullish Forecast For King Crypto Hinges On This Condition</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40950912/bitcoins-reserve-asset-appeal-increased-due-to-state-of-us-federal-deficit-and-debt-says-b">Bitcoin&#8217;s Reserve Asset Appeal Increased Due To State Of US Federal Deficit And Debt, Says BlackRock: A Hedge Against &#8216;Possible Future Events&#8217; Affecting The Dollar</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40956111/pepe-leapfrogs-dogecoin-shiba-inu-in-30-day-gains-trading-volume-no-one-is-bullish-enough-">Pepe Leapfrogs Dogecoin, Shiba Inu In 30-Day Gains, Trading Volume: &#8216;No One Is Bullish Enough,&#8217; Says Trader</a></li>
</ul>
US Politics
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40956172/trump-vs-harris-will-warren-buffett-display-a-blue-or-red-dot-in-his-front-yard-neighbors-wait-to-se">Trump Vs. Harris: Will Warren Buffett Display A Blue Or Red Dot In His Front Yard? Neighbors Wait To See Who The Oracle Of Omaha Is Supporting</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40953535/anybody-who-votes-for-a-democrat-or-kamala-worst-you-should-have-your-head-examined-trump-tells-vote">&#8216;Anybody Who Votes For A Democrat Or Kamala, Worst…You Should Have Your Head Examined:&#8217; Trump Tells Voters In Washington As Poll Numbers Plummet</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40952944/anthony-scaramucci-says-trumps-3-legged-stool-strategy-of-racism-misogyny-and-anti-immigration-will">Anthony Scaramucci Says Trump&#8217;s 3-Legged Stool Strategy Of &#8216;Racism, Misogyny And Anti-Immigration&#8217; Will Misfire: Here&#8217;s What Would Seal The Deal For Kamala Harris</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40951090/kamala-harris-underlines-her-support-for-second-amendment-dismisses-false-dichotomy-of-gun-control-d">Kamala Harris Underlines Her Support For Second Amendment, Dismisses False Dichotomy Of Gun Control Debate: Jokes To Oprah: &#8216;If Somebody Breaks In My House They Getting Shot&#8217;</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40950764/kamala-harris-tells-oprah-winfrey-she-felt-a-sense-of-responsibility-after-bidens-sudden-exit-it-cam">Kamala Harris Tells Oprah Winfrey She Felt A &#8216;Sense Of Responsibility&#8217; After Biden&#8217;s Sudden Exit: It Came With A &#8216;Sense of Purpose&#8217;</a></li>
</ul>
US Markets­­­­­­­­
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40954521/wall-street-looks-to-pause-after-s-ps-record-performance-as-fed-rate-cut-euphoria-fades-and-hard-la">Wall Street Looks To Pause After S&amp;P&#8217;s Record Performance As Fed Rate-Cut Euphoria Fades And Hard-Landing Fears Surface</a></li>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40952252/nvidia-tesla-rally-as-dow-s-p-500-surge-to-fresh-highs-after-fed-cuts-rates-fear-index-remains-in-g">Nvidia, Tesla Rally As Dow, S&amp;P 500 Surge To Fresh Highs After Fed Cuts Rates: Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>
World Politics
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40955425/top-us-officials-skeptical-of-israel-hamas-cease-fire-and-hostage-deal-before-bidens-term-ends-repor">Top US Officials Skeptical Of Israel-Hamas Cease-Fire And Hostage Deal Before Biden&#8217;s Term Ends: Report</a></li>
<li><a href="https://www.benzinga.com/24/09/40954613/kim-jong-uns-show-of-force-with-missiles-indicates-north-korea-is-no-longer-interested-in-negotiatio">Kim Jong Un&#8217;s &#8216;Show Of Force&#8217; With Missiles Indicates North Korea Is No Longer Interested In Negotiations With US, Say Analysts</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40952025/us-keeps-missiles-vital-for-defence-of-taiwan-in-philippines-despite-beijings-demands-for-removal-re">US Keeps Missiles Vital For Defence Of Taiwan In Philippines Despite Beijing&#8217;s Demands For Removal: Report</a></li>
</ul>
US Economy
<ul>
<li><a href="https://www.benzinga.com/real-estate/24/09/40955378/mortgage-rates-drop-but-homebuyers-still-say-no-thanks-heres-whats-really-behind-the-buyer-strike">Mortgage Rates Drop, But Homebuyers Still Say &#8216;No Thanks&#8217;– Here&#8217;s What&#8217;s Really Behind The Buyer Strike</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40950904/claudia-sahm-underscores-feds-mandate-to-protect-jobs-says-additional-cuts-expected-the-time-to-supp">Claudia Sahm Underscores Fed&#8217;s Mandate to Protect Jobs, Says Additional Cuts Expected: &#8216;The Time To Support The Labor Market Is When It&#8217;s Strong&#8217;</a></li>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40955933/brace-for-stagflation-after-feds-benevolence-warns-analyst-raising-5-corporate-red-">Brace For Stagflation After Fed&#8217;s Benevolence, Warns Analyst, Raising 5 Corporate Red Flags: &#8216;Inflation Is Transitory Mistake All Over Again&#8217;</a></li>
</ul>
World Economy
<ul>
<li><a href="https://www.benzinga.com/markets/asia/24/09/40954672/asia-markets-advance-europe-edges-lower-and-gold-clocks-new-high-at-2-630-global-markets-overview">Asia Markets Advance, Europe Edges Lower And Gold Clocks New High At $2,630 – Global Markets Overview</a></li>
<li><a href="https://www.benzinga.com/markets/asia/24/09/40951221/bank-of-japan-leaves-interest-rate-at-0-25-diverging-from-feds-50-basis-point-cut">Bank Of Japan Leaves Interest Rate At 0.25%, Diverging From Fed&#8217;s 50 Basis Point Cut</a></li>
</ul>
Tech
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/09/40954565/amazon-extends-free-prime-membership-to-warehouse-workers-but-corporate-staff-left-out-ahea">Amazon Extends Free Prime Membership To Warehouse Workers, But Corporate Staff Left Out Ahead Of Holiday Rush</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40954193/salesforce-ceo-marc-benioff-slams-microsofts-copilot-compares-it-to-failed-clippy-assistant-like-wer">Salesforce CEO Marc Benioff Slams Microsoft&#8217;s Copilot, Compares It To Failed &#8216;Clippy&#8217; Assistant: &#8216;…Like We&#8217;re Selling Science Projects To Companies&#8217;</a></li>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40953906/huaweis-2-800-tri-fold-mate-xt-sparks-frustration-as-limited-stock-fails-to-meet-demand">Huawei&#8217;s $2,800 Tri-Fold Mate XT Sparks Frustration As Limited Stock Fails To Meet Demand</a></li>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40951144/tesla-nike-alibaba-fedex-trump-media-technology-why-these-5-stocks-are-on-investors-radars-today">Tesla, Nike, Alibaba, FedEx, Trump Media &amp; Technology: Why These 5 Stocks Are On Investors&#8217; Radars Today</a></li>
</ul>
Electric Vehicle
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40954673/rivian-introduces-100k-tri-max-variant-of-r1s-electric-suv-on-online-shop-which-can-go-from-0-60-mph">Rivian Introduces $100K Tri Max Variant Of R1S Electric SUV On Online Shop Which Can Go from 0-60 MPH In 3s</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40953641/alphabets-waymo-hyundai-in-talks-to-use-ioniq-5-suvs-as-robotaxis-report">Alphabet&#8217;s Waymo, Hyundai In Talks To Use Ioniq 5 SUVs As Robotaxis: Report</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40952233/gms-cruise-eyes-resuming-robotaxi-operations-in-california-after-long-pause-due-to-pedestrian-accide">GM&#8217;s Cruise Eyes Resuming Robotaxi Operations In California After Long Pause Due To Pedestrian Accident In 2023</a></li>
</ul>
Consumer
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40955424/gm-to-recall-nearly-450k-vehicles-over-inoperative-warning-lights-on-loss-of-brake-fluid">GM To Recall Nearly 450K Vehicles Over Inoperative Warning Lights On Loss Of Brake Fluid</a></li>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40955083/holiday-opportunity-macys-plans-to-hire-31-500-seasonal-workers">Holiday Opportunity: Macy&#8217;s Plans To Hire 31,500 Seasonal Workers</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40954074/why-nike-shares-are-trading-higher-by-around-7-here-are-20-stocks-moving-premarket">Why Nike Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket</a></li>
</ul>
Communication
<ul>
<li><a href="https://www.benzinga.com/general/entertainment/24/09/40954271/netflix-boosts-its-burgeoning-game-library-with-civilization-vi-and-street-fighter-iv-and-y">Netflix Boosts Its Burgeoning Game Library With Civilization VI And Street Fighter IV, And You Can Play Them At No Extra Cost</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40953653/tesla-bull-pierre-ferragu-calls-elon-musks-x-update-revolutionary-urges-for-a-custom-x-browser-this">Tesla Bull Pierre Ferragu Calls Elon Musk&#8217;s X Update Revolutionary, Urges For A Custom X Browser: &#8216;This Is Wikipedia To The Power Of Infinity&#8217;</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40952310/elon-musks-x-fined-1m-a-day-by-brazils-supreme-court-for-defying-ban-on-platform-judge-says-part-of">Elon Musk&#8217;s X Fined $1M A Day By Brazil&#8217;s Supreme Court For Defying Ban On Platform: Judge Says Part Of Effort To &#8216;Clean Up The Internet&#8217;</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40951748/there-is-no-escaping-youtube-ads-even-after-hitting-the-pause-button-disgruntled-users-cry-foul-an-a">There Is No Escaping YouTube Ads Even After Hitting The Pause Button — Disgruntled Users Cry Foul: &#8216;An Absolute Trash Idea&#8217;</a></li>
</ul>
Healthcare
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/09/40956171/european-drug-agency-supports-novo-nordisks-blockbuster-weight-loss-drug-wegovy-for-obesity-relat">European Drug Agency Supports Novo Nordisk&#8217;s Blockbuster Weight-Loss Drug Wegovy For Obesity-Related Heart Failure</a></li>
</ul>
General
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40951997/palantir-co-founder-joe-lonsdale-backs-elon-musks-twitter-acquisition-saying-if-he-had-not-bought-it">Palantir Co-Founder Joe Lonsdale Backs Elon Musk&#8217;s Twitter Acquisition, Saying If He Had Not Bought It Then &#8216;The Entire West Would Be At 10x The Threat&#8217;</a></li>
<li><a href="https://www.benzinga.com/news/24/09/40950634/the-secret-service-is-aware-of-the-social-media-post-made-by-elon-musk-says-law-enforcement-agency">&#8216;The Secret Service Is Aware Of The Social Media Post Made By Elon Musk,&#8217; Says Law Enforcement Agency</a></li>
</ul>
Space
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40951122/elon-musk-blasts-faa-for-targeting-spacex-over-petty-matters-while-ignoring-boeings-safety-issue">Elon Musk Blasts FAA For Targeting SpaceX Over &#8216;Petty Matters,&#8217; While Ignoring Boeing&#8217;s Safety Issues: This &#8216;Puts Human Lives At Risk&#8217;</a></li>
</ul>
Energy
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/09/40954292/conocophillips-uniper-ink-10-year-gas-supply-deal">ConocoPhillips, Uniper Ink 10-Year Gas Supply Deal</a></li>
</ul>
Photo by Roy Buri via Pixabay

$BTC

$ETH

Bitcoin's Correction Ends, But Must Hit A Key Target To Reach $70K, Says 10x Research; European Drug Agency Backs Novo Nordisk's Wegovy For Obesity-Related Heart Failure - Top Headlines Today While US Slept

TTOO

T2 Biosystems Successfully Defends Patent For Direct-From-Whole Blood Pathogen Detection Method In European Union, Maintaining Strong IP Position

Nike Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) has appointed company veteran Elliott Hill as its new CEO, aiming to rejuvenate sales by mending ties with retailers.
What Happened: Hill&#8217;s appointment comes as John Donahoe steps down after a tenure focused on direct-to-consumer sales. This strategy, which emphasized selling through Nike&#8217;s stores and website, faced criticism for sidelining retail partners like Foot Locker and Macy&#8217;s, Reuters reported on Friday.
Under Donahoe, Nike&#8217;s shares have dropped by 25% this year. However, the announcement of Hill&#8217;s leadership saw a 6% surge in premarket trading on Friday, signaling investor optimism.
Morningstar analyst David Swartz noted that Nike&#8217;s board, including the controlling Knight family, sought a leader with deep company knowledge to address recent challenges, particularly the strained retailer relationships.
Nike aims to regain market share, especially in the running category, by spotlighting performance products and introducing new budget-friendly sneakers. A detailed strategy from Hill is expected at the company&#8217;s investor day in November.
See Also: <a href="https://www.benzinga.com/markets/cannabis/24/09/40885286/just-smoke-the-weed-why-this-physician-in-california-urges-against-cannabis-vaping?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">&#8216;Just Smoke Weed&#8217;: This Physician Urges Against Cannabis Vaping</a>
Why It Matters: The leadership change comes at a crucial time for Nike, which has been grappling with a series of challenges. Earlier this year, Nike&#8217;s <a href="https://www.benzinga.com/24/06/39553700/nikes-fourth-quarter-results-highlight-its-struggle-with-ongoing-challenges">fourth-quarter results </a>highlighted ongoing struggles, with shares plunging more than 12% in after-hours trading. Despite being the top sponsor at the UEFA Euro 2024 football tournament, Nike&#8217;s lack of innovation and quality storytelling has hurt its performance. The company also lowered its full-year sales outlook, rattling stocks of retail partners like Foot Locker and Dick&#8217;s Sporting Goods.
Nike&#8217;s strategy to shift away from <a href="https://www.benzinga.com/news/24/09/40954074/why-nike-shares-are-trading-higher-by-around-7-here-are-20-stocks-moving-premarket">wholesalers to direct sales</a> channels has contributed to its sales slump. However, key retail partners have expressed optimism about Nike&#8217;s upcoming product launches and innovations. Foot Locker noted that Nike is &#8220;clearly back to playing offense.&#8221; For the quarter ending May 31st, Nike reported a 2% revenue decrease to $12.61 billion.
Price Action: At the time of writing, Nike was up by 8.36% in the pre-market on Friday, as per <a href="https://pro.benzinga.com">Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40892040/starbucks-north-america-ceo-michael-conway-quits-after-just-6-months-in-the-position?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Starbucks North America CEO Michael Conway Quits After Just 6 Months In The Position</a></li>
</ul>
Image via Pexels/ Grailify
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

General

Nike's New CEO Elliott Hill To Focus On Repairing Retailer Relations

Buybacks

SRBK

SR Bancorp Adopted Repurchase Program Of Up To 950,793 Shares

Evercore ISI Group analyst Jonathan Chappell maintains FedEx (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) with a Outperform and lowers the price target from $335 to $318.

Evercore ISI Group Maintains Outperform on FedEx, Lowers Price Target to $318

Qualigen Therapeutics, Inc. - Common Stock

QLGN

Qualigen Therapeutics Granted Nasdaq Extension To Meet Compliance Requirements For Continued Listing By November 19, 2024

Short Sellers

Short Ideas

INTU

Spruce Point Capital Issues Strong Sell Opinion On Intuit, Citing Lack Of Transparency, Competitive Threats, And Predicting 40%-80% Long-Term Downside

Apollo's ATLAS SP And BNP Paribas Announce $5B Strategic Collaboration

Annaly Capital Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NLY#NYSE">NLY</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $22.12, with a high estimate of $23.50 and a low estimate of $21.00. This current average reflects an increase of 7.9% from the previous average price target of $20.50. 
<img src="https://www.benzinga.com/files/images/story/2024/1726837252_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
In examining recent analyst actions, we gain insights into how financial experts perceive Annaly Capital Management. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Donald Fandetti</td>
<td>Wells Fargo</td>
<td>Raises</td>
<td>Overweight</td>
<td>$23.00</td>
<td>$19.00</td>
</tr>
<tr>
<td>Merrill Ross</td>
<td>Compass Point</td>
<td>Raises</td>
<td>Buy</td>
<td>$23.50</td>
<td>$22.00</td>
</tr>
<tr>
<td>Jason Weaver</td>
<td>Jones Trading</td>
<td>Maintains</td>
<td>Buy</td>
<td>$21.00</td>
<td>$21.00</td>
</tr>
<tr>
<td>Richard Shane</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Overweight</td>
<td>$21.00</td>
<td>$20.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Annaly Capital Management. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Annaly Capital Management compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Annaly Capital Management's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Annaly Capital Management's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/NLY/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Annaly Capital Management analyst ratings.</a>
<h2>All You Need to Know About Annaly Capital Management</h2>
Annaly Capital Management Inc is an American mortgage real estate investment trust. The Company owns a portfolio of real estate related investments, including mortgage pass-through certificates, collateralized mortgage obligations, credit risk transfer securities, other securities representing interests in or obligations backed by pools of mortgage loans, residential mortgage loans and mortgage servicing rights. Its business objective is to generate net income for distribution to its stockholders and optimize its returns through prudent management of its diversified investment strategies. The Company's three investment groups are comprised of the following: Annaly Agency Group, Annaly Residential Credit Group, Annaly Mortgage Servicing Rights Group.
<h3>Key Indicators: Annaly Capital Management's Financial Health</h3>
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Negative Revenue Trend: Examining Annaly Capital Management's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -78.02% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Financials sector.
Net Margin: Annaly Capital Management's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -97.19%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -0.48%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Annaly Capital Management's ROA is below industry averages, indicating potential challenges in efficiently utilizing assets. With an ROA of -0.05%, the company may face hurdles in achieving optimal financial returns.
Debt Management: Annaly Capital Management's debt-to-equity ratio is below the industry average. With a ratio of 1.82, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>Analyst Ratings: What Are They?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Critical Insights From Annaly Capital Management Analyst Ratings: What You Need To Know

The U.S. dollar plunged to a 17-month low against the Chinese yuan after the Federal Reserve slashed rates as the People&#8217;s Bank of China held them steady overnight, raising pressures on interest-rate divergences between the <a href="https://www.benzinga.com/topic/china">world&#8217;s two major economies. </a>
The People Bank of China (PBoC) opted to hold the one-year loan prime rate (LPR)—a critical benchmark for most corporate and household loans—at 3.35% during its September fixing. The five-year LPR, a reference for property mortgages, also remained steady at 3.85%.
According to the latest monetary report, China's economy grew by 5% year over year in the first half of 2024, showing resilience despite a complex global environment.
Inflation remained subdued, with the consumer price index (CPI) increasing by just 0.1% year-over-year. The central bank noted that while economic performance was stable, domestic issues such as &#8220;insufficient effective demand&#8221; and &#8220;the transition to new growth drivers&#8221; continue to challenge the economy.
The PBoC&#8217;s accommodative monetary stance is designed to provide necessary financial support for a sustainable economic recovery. However, it highlighted that external conditions remain &#8220;complex, grim, and uncertain,&#8221; contributing to a cautious approach to navigating headwinds.
<h3 class="wp-block-heading">Chinese Stock Market Performance</h3>
Chinese domestic stocks, as tracked by the Shanghai Composite Total Return Index, closed flat for the day, reflecting market uncertainty. However, offshore Chinese stocks fared better, with Hong Kong-listed entities, tracked via the iShares MSCI Hong Kong Index Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EWH#NYSE">EWH</a>), advancing by more than 1%.
In U.S. premarket trading, major Chinese stocks listed on American exchanges also saw gains:
<ul>
<li>XPeng Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>): +3.3%</li>
<li>Li Auto Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LI#NASDAQ">LI</a>): +1.5%</li>
<li>Alibaba Group Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>): +1.3%</li>
<li>Tencent Music Entertainment Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TME#NYSE">TME</a>): +0.8%</li>
</ul>
<h3 class="wp-block-heading">Bank of Japan Holds Rates; Yen Slips</h3>
In Eastern Asia, the Bank of Japan (BoJ) also held interest rates steady at 0.25%, aligning with market expectations. 
Japan's economy showed a moderate recovery, though signs of weakness were observed in certain sectors, according to the BoJ statement.
On the inflation front, Japan's core CPI (excluding fresh food) has risen by 2.5-3.0% year-over-year, driven by wage increases and moderate price hikes in services.
Following this announcement, the Japanese yen, tracked by the Invesco CurrencyShares Japanese Yen Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FXY#NYSE">FXY</a>), fell by over 1% against the U.S. dollar. Meanwhile, Japanese equities rallied, with the Nikkei 225 index, as represented by the iShares MSCI Japan Index Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EWJ#NYSE">EWJ</a>), surging by 1.5% after a 3% gain in the earlier session.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40948624/traders-brace-for-friday-volatility-as-over-5-trillion-in-options-expire-could-trip">Traders Brace For Friday Volatility As Over $5 Trillion In Options Expire: Could &#8216;Triple Witching&#8217; Spoil Fed&#8217;s Rally?</a></li>
</ul>
Photo: Shutterstock

Asia

Currency ETFs

Global

Federal Reserve

Tech

ETFs

BABA

XPEV

Interest Rate Divergence Weakens Dollar To 17-Month Low Against Yuan: XPeng, Li Auto Among 4 Stock Movers

Trupanion (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRUP#NASDAQ">TRUP</a>) underwent analysis by 6 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Insights from analysts' 12-month price targets are revealed, presenting an average target of $39.0, a high estimate of $56.00, and a low estimate of $30.00. Marking an increase of 25.81%, the current average surpasses the previous average price target of $31.00. 
<img src="https://www.benzinga.com/files/images/story/2024/1726837243_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The standing of Trupanion among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Joshua Shanker</td>
<td>B of A Securities</td>
<td>Raises</td>
<td>Buy</td>
<td>$56.00</td>
<td>$47.00</td>
</tr>
<tr>
<td>Greg Gibas</td>
<td>Northland Capital Markets</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$45.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Greg Gibas</td>
<td>Northland Capital Markets</td>
<td>Raises</td>
<td>Market Perform</td>
<td>$35.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>John Barnidge</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$38.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Jonathan Block</td>
<td>Stifel</td>
<td>Raises</td>
<td>Hold</td>
<td>$30.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>John Barnidge</td>
<td>Piper Sandler</td>
<td>Raises</td>
<td>Neutral</td>
<td>$30.00</td>
<td>$22.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Trupanion. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Trupanion compared to the broader market.</li>
<li>Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Trupanion's stock. This examination reveals shifts in analysts' expectations over time.</li>
</ul>
Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Trupanion's market standing. Stay informed and make data-driven decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/TRUP/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Trupanion analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>All You Need to Know About Trupanion</h2>
Trupanion Inc is a specialty insurance products provider in the United States. Its core business is the sale of insurance products tailor-made for pets, especially cats and dogs. It operates in two business segments: The subscription business segment generates revenue primarily from subscription fees related to the Company's direct-to-consumer products and Other business segment is comprised of revenue from other product offerings that generally have a business-to-business relationship and a different margin profile than subscription business segment, including revenue from writing policies on behalf of third parties and revenue from other products and software solutions.
<h3>Trupanion's Economic Impact: An Analysis</h3>
Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.
Revenue Growth: Trupanion's revenue growth over a period of 3 months has been noteworthy. As of 30 June, 2024, the company achieved a revenue growth rate of approximately 16.35%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Trupanion's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -1.86%, the company may encounter challenges in effective cost control.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -1.92%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Trupanion's ROA is below industry standards, pointing towards difficulties in efficiently utilizing assets. With an ROA of -0.74%, the company may encounter challenges in delivering satisfactory returns from its assets.
Debt Management: Trupanion's debt-to-equity ratio is below the industry average at 0.42, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

TRUP

Unveiling 6 Analyst Insights On Trupanion

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a<a href="https://www.benzinga.com/yield-investments"> high dividend payout</a>.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting <a href="https://www.benzinga.com/analyst-stock-ratings">Analyst Stock Ratings</a> page. Traders can sort through Benzinga's extensive database of analyst ratings, including <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">by analyst accuracy</a>.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the health care sector.
<h3 class="wp-block-heading">Pfizer Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PFE#NYSE">PFE</a>)</h3>
Dividend Yield: 5.66%
<ul>
<li>Cantor Fitzgerald analyst Louise Chen reiterated an Overweight rating with a price target of $45 on Sept. 16. This analyst has an accuracy rate of 70%.</li>
<li>Wells Fargo analyst Mohit Bansal maintained an Equal-Weight rating and raised the price target from $28 to $30 on July 31. This analyst has an accuracy rate of 78%.</li>
<li>Recent News: Pfizer recently presented positive data from Phase 2 study of Ponsegromab in Patients with cancer cachexia.</li>
<li>Benzinga Pro's real-time newsfeed alerted to<a href="https://pro.benzinga.com/dashboard"> latest PFE news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="906" height="835" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20052536/image-161.png" alt="" class="wp-image-557905" style="width:703px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20052536/image-161.png 906w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20052536/image-161-300x276.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20052536/image-161-768x708.png 768w" sizes="(max-width: 906px) 100vw, 906px" /></a></figure>
<h3 class="wp-block-heading">CVS Health Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVS#NYSE">CVS</a>)</h3>
<ul>
<li>Dividend Yield: 4.55%</li>
<li>RBC Capital analyst Ben Hendrix reiterated an Outperform rating with a price target of $68 on Sept. 4. This analyst has an accuracy rate of 74%</li>
<li>Barclays analyst Andrew Mok maintained an Equal-Weight rating and cut the price target from $65 to $63 on Aug. 8. This analyst has an accuracy rate of 79%.</li>
<li>Recent News: Wednesday, Oak Street Health, a subsidiary of CVS Health, agreed to settle for $60 million following allegations that it violated the False Claims Act.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the <a href="https://pro.benzinga.com/dashboard">trend in CVS stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="908" height="855" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20052607/image-162.png" alt="" class="wp-image-557908" style="width:653px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20052607/image-162.png 908w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20052607/image-162-300x282.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20052607/image-162-768x723.png 768w" sizes="(max-width: 908px) 100vw, 908px" /></a></figure>
<h3 class="wp-block-heading">Gilead Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GILD#NASDAQ">GILD</a>)</h3>
<ul>
<li>Dividend Yield: 3.67%</li>
<li>RBC Capital analyst Brian Abrahams maintained a Sector Perform rating and raised the price target from $72 to $74 on Sept. 4. This analyst has an accuracy rate of 65%.</li>
<li>Needham analyst Joseph Stringer reiterated a Hold rating on Aug. 15. This analyst has an accuracy rate of 80%.</li>
<li>Recent News: Gilead Sciences, last week, revealed the results of an interim analysis from a second Phase 3 trial investigating the use of the company's twice-yearly injectable HIV-1 capsid inhibitor, lenacapavir.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://pro.benzinga.com/dashboard">breakout in GILD shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://pro.benzinga.com/dashboard"><img loading="lazy" decoding="async" width="891" height="841" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20052656/image-163.png" alt="" class="wp-image-557910" style="width:574px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20052656/image-163.png 891w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20052656/image-163-300x283.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20052656/image-163-768x725.png 768w" sizes="(max-width: 891px) 100vw, 891px" /></a></figure>
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="How to Find Dividend Stocks: Scan, Analyze, and Capture with Benzinga Pro" width="500" height="281" src="https://www.youtube.com/embed/pVF0O2lsEH4?start=1&#038;feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40952252/nvidia-tesla-rally-as-dow-s-p-500-surge-to-fresh-highs-after-fed-cuts-rates-fear-index-remains-in-g">Nvidia, Tesla Rally As Dow, S&amp;P 500 Surge To Fresh Highs After Fed Cuts Rates: Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

Dividends

Pre-Market Outlook

GILD

Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields

Analysts' ratings for Cisco Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) over the last quarter vary from bullish to bearish, as provided by 8 analysts.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Cisco Systems and provided 12-month price targets. The average target is $55.0, accompanied by a high estimate of $60.00 and a low estimate of $49.00. Witnessing a positive shift, the current average has risen by 4.9% from the previous average price target of $52.43.
<img src="https://www.benzinga.com/files/images/story/2024/1726837230_0.png" alt="price target chart" />
<h2>Exploring Analyst Ratings: An In-Depth Overview</h2>
The analysis of recent analyst actions sheds light on the perception of Cisco Systems by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Amit Daryanani</td>
<td>Evercore ISI Group</td>
<td>Raises</td>
<td>Outperform</td>
<td>$60.00</td>
<td>$55.00</td>
</tr>
<tr>
<td>Stephen Bersey</td>
<td>HSBC</td>
<td>Raises</td>
<td>Buy</td>
<td>$58.00</td>
<td>$46.00</td>
</tr>
<tr>
<td>Pierre Ferragu</td>
<td>New Street Research</td>
<td>Announces</td>
<td>Buy</td>
<td>$57.00</td>
<td>-</td>
</tr>
<tr>
<td>James Fish</td>
<td>Piper Sandler</td>
<td>Maintains</td>
<td>Neutral</td>
<td>$52.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>George Notter</td>
<td>Jefferies</td>
<td>Lowers</td>
<td>Buy</td>
<td>$53.00</td>
<td>$56.00</td>
</tr>
<tr>
<td>Matthew Niknam</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Hold</td>
<td>$53.00</td>
<td>$52.00</td>
</tr>
<tr>
<td>Tim Long</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$49.00</td>
<td>$50.00</td>
</tr>
<tr>
<td>Mike Genovese</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Neutral</td>
<td>$58.00</td>
<td>$56.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Cisco Systems. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Analyzing trends, analysts offer qualitative evaluations, ranging from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Cisco Systems compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Cisco Systems's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Cisco Systems's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/CSCO/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Cisco Systems analyst ratings.</a>
<h2>All You Need to Know About Cisco Systems</h2>
Cisco Systems is the largest provider of networking equipment in the world and one of the largest software companies in the world. Its largest businesses are selling networking hardware and software (where it has leading market shares) and cybersecurity software such as firewalls. It also has collaboration products, like its Webex suite, and observability tools. It primarily outsources its manufacturing to third parties and has a large sales and marketing staff—25,000 strong across 90 countries. Overall, Cisco employs 80,000 people and sells its products globally.
<h3>Cisco Systems: Financial Performance Dissected</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Challenges: Cisco Systems's revenue growth over 3 months faced difficulties. As of 31 July, 2024, the company experienced a decline of approximately -10.27%. This indicates a decrease in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Information Technology sector.
Net Margin: Cisco Systems's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 15.85% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 4.74%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Cisco Systems's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.75%, the company showcases efficient use of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.68, Cisco Systems adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Significance of Analyst Ratings Explained</h2>
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cracking The Code: Understanding Analyst Reviews For Cisco Systems

Across the recent three months, 22 analysts have shared their insights on Confluent (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CFLT#NASDAQ">CFLT</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">10</td>
<td style="text-align: right;">7</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">8</td>
<td style="text-align: right;">5</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Confluent, presenting an average target of $29.95, a high estimate of $38.00, and a low estimate of $23.00. Experiencing a 13.81% decline, the current average is now lower than the previous average price target of $34.75. 
<img src="https://www.benzinga.com/files/images/story/2024/1726837219_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The perception of Confluent by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Chirag Ved</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$28.00</td>
<td>$33.00</td>
</tr>
<tr>
<td>Rudy Kessinger</td>
<td>DA Davidson</td>
<td>Maintains</td>
<td>Buy</td>
<td>$30.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>William Power</td>
<td>Baird</td>
<td>Announces</td>
<td>Neutral</td>
<td>$23.00</td>
<td>-</td>
</tr>
<tr>
<td>Pinjalim Bora</td>
<td>JP Morgan</td>
<td>Announces</td>
<td>Overweight</td>
<td>$25.00</td>
<td>-</td>
</tr>
<tr>
<td>Derrick Wood</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Buy</td>
<td>$31.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Nick Altmann</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$25.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Brad Zelnick</td>
<td>Deutsche Bank</td>
<td>Lowers</td>
<td>Buy</td>
<td>$30.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Raimo Lenschow</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$29.00</td>
<td>$34.00</td>
</tr>
<tr>
<td>Rob Owens</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$32.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Matthew Hedberg</td>
<td>RBC Capital</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$30.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Rudy Kessinger</td>
<td>DA Davidson</td>
<td>Lowers</td>
<td>Buy</td>
<td>$30.00</td>
<td>$37.00</td>
</tr>
<tr>
<td>Brad Reback</td>
<td>Stifel</td>
<td>Lowers</td>
<td>Buy</td>
<td>$32.00</td>
<td>$40.00</td>
</tr>
<tr>
<td>Michael Turrin</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$34.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Miller Jump</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$30.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Kingsley Crane</td>
<td>Canaccord Genuity</td>
<td>Lowers</td>
<td>Buy</td>
<td>$34.00</td>
<td>$35.00</td>
</tr>
<tr>
<td>Mike Cikos</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$28.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Brad Sills</td>
<td>B of A Securities</td>
<td>Lowers</td>
<td>Underperform</td>
<td>$26.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Tyler Radke</td>
<td>Citigroup</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$28.00</td>
<td>$32.00</td>
</tr>
<tr>
<td>Mike Cikos</td>
<td>Needham</td>
<td>Maintains</td>
<td>Buy</td>
<td>$38.00</td>
<td>$38.00</td>
</tr>
<tr>
<td>Yun Kim</td>
<td>Loop Capital</td>
<td>Lowers</td>
<td>Hold</td>
<td>$25.00</td>
<td>$30.00</td>
</tr>
<tr>
<td>Gregg Moskowitz</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$34.00</td>
<td>$36.00</td>
</tr>
<tr>
<td>Howard Ma</td>
<td>Guggenheim</td>
<td>Maintains</td>
<td>Buy</td>
<td>$37.00</td>
<td>$37.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Confluent. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Confluent compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
To gain a panoramic view of Confluent's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/CFLT/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Confluent analyst ratings.</a>
<h2>Discovering Confluent: A Closer Look</h2>
Confluent Inc is a new category of data infrastructure designed to connect all the applications, systems, and data layers of a company around a real-time central nervous system. Its products include Confluent Platform; Connectors; ksqlDB and others. The company generates revenue from the sale of subscriptions and services. Geographically, it derives a majority of its revenue from the United States. The company provides solutions to Financial Services; Insurance; Retail and eCommerce; Automotive; Government and other sectors.
<h3>Breaking Down Confluent's Financial Performance</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Confluent's remarkable performance in 3 months is evident. As of 30 June, 2024, the company achieved an impressive revenue growth rate of 24.14%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.
Net Margin: Confluent's net margin falls below industry averages, indicating challenges in achieving strong profitability. With a net margin of -38.26%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of -10.46%, the company may need to address challenges in generating satisfactory returns for shareholders.
Return on Assets (ROA): Confluent's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -3.62%, the company may face hurdles in achieving optimal financial performance.
Debt Management: With a high debt-to-equity ratio of 1.27, Confluent faces challenges in effectively managing its debt levels, indicating potential financial strain.
<h2>The Basics of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

CFLT

Breaking Down Confluent: 22 Analysts Share Their Views

WHLRL

Trading Halt: Halt status updated at 9:00:00 AM ET: Quotation Resumption: News and Resumption Times

Evercore ISI Group analyst Michael Binetti maintains Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) with a Outperform and raises the price target from $105 to $110.

Evercore ISI Group Maintains Outperform on Nike, Raises Price Target to $110

The U.S. and Taiwan are initiating collaboration between their drone companies to create supply chains independent of China. Executives from 26 U.S. drone and anti-drone companies will arrive in Taipei on Sunday for three days of meetings with Taiwanese counterparts, military officials, and researchers.
What Happened: The delegation includes officials from the U.S. Commerce Department, the Pentagon's Defense Innovation Unit, and Dev Shenoy, head of the Defense Department's microelectronics research and engineering. The visit underscores efforts to &#8220;de-risk&#8221; supply chains amid U.S.-China competition and security concerns over Chinese products with dual civilian and military uses, Financial Times <a href="https://www.ft.com/content/ce851c48-6aa5-48d2-b28a-6c806cc10518">reported</a> on Friday
The mission aims to help US companies find non-Chinese component suppliers or manufacturing partners. Taiwan's Defence Minister, Wellington Koo, stated that the visit is an opportunity for Taiwan to integrate into U.S. supply chains and engage in co-production. This integration could help Taiwan overcome export challenges due to its international status and pressure from China.
Among the visiting companies are AeroVironment , Dedrone, and Northrop Grumman . Taiwan's government is also boosting its drone industry, awarding NT$6.8bn ($210mn) in defence ministry orders to private companies for autonomous platforms, including microdrones and ship-borne reconnaissance drones.
See Also: <a href="https://www.benzinga.com/news/24/09/40890590/chuck-schumer-says-if-government-shutdown-happens-it-will-because-of-republican-poison-pills-the-ame?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Chuck Schumer Says If Government Shutdown Happens It Will Be Because Of &#8216;Republican Poison Pills&#8217; — &#8216;The  American People Are Going To Hold Them Responsible&#8217;</a>
Why It Matters: The collaboration between the US and Taiwan in the drone industry comes amid rising tensions with China. Recently, the US Air Force has been testing AI-powered drones, such as the <a href="https://www.benzinga.com/government/23/08/34096150/us-air-force-testing-ai-powered-enemy-fighting-drones-as-china-taiwan-tensions-simmer">XQ-58A Valkyrie</a>, which can significantly alter military warfare by evaluating enemy threats and carrying missiles.
Additionally, the US has approved a <a href="https://www.benzinga.com/news/24/09/40892360/us-approves-228m-military-sale-to-taiwan-to-boost-aircraft-combat-readiness-amid-rising-tensions-wit">$228 million military sale</a> to Taiwan to enhance its aircraft combat readiness. This move is part of a broader strategy to support Taiwan&#8217;s defense capabilities.
Moreover, the US has decided to keep a mid-range missile system in the Philippines, despite China&#8217;s demands for its removal. This <a href="https://www.benzinga.com/news/24/09/40952025/us-keeps-missiles-vital-for-defence-of-taiwan-in-philippines-despite-beijings-demands-for-removal-re">Typhon missile system</a> is seen as crucial for defending Taiwan in the event of a Chinese attack.
China has issued stern warnings to the US regarding interference in its sovereignty. Chinese Ambassador Xie Feng emphasized that the <a href="https://www.benzinga.com/news/24/09/40851594/chinese-ambassador-issues-stern-warning-to-us-on-red-lines-taiwan-question-is-the-most-paramount-and">Taiwan question</a> is a critical &#8220;red line&#8221; in US-China relations.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/09/40897703/former-tesla-exec-says-elon-musks-endorsement-of-trump-might-not-sway-upcoming-presidential-election?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Former Tesla Exec Says Elon Musk&#8217;s Endorsement Of Trump Might Not Sway Upcoming Presidential Elections: &#8216;Last Time Around He Endorsed Andrew Yang&#8217;</a></li>
</ul>
Image via Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

Politics

Amid China Threat, US And Taiwan Team Up To Boost Drone Industry Cooperation To 'De-Risk' Supply Chains

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5804bb14846faa000106aa5f/dara-mohsenian">Morgan Stanley analyst Dara Mohsenian</a> downgraded the rating for PepsiCo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) from Overweight to Equal-Weight and maintained the price target of $185. PepsiCo shares fell 0.3% to close at $174.66 on Thursday. <a href="https://www.benzinga.com/quote/PEP/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Bernstein analyst Danilo Gargiulo downgraded Darden Restaurants, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DRI#NYSE">DRI</a>) from Outperform to Market Perform and lowered the price target from $190 to $180. Darden shares gained 8.3% to close at $172.27 on Thursday. <a href="https://www.benzinga.com/quote/DRI/analyst-ratings">See how other analysts view this stock.</a></li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5e58f002ece4e6000120bf6b/silvan-tuerkcan">JMP Securities analyst Silvan Tuerkcan</a> downgraded Notable Labs, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTBL#NASDAQ">NTBL</a>) from Market Outperform to Market Perform. Notable Labs shares gained 5.5% to close at $0.4780 on Thursday. <a href="https://www.benzinga.com/quote/NTBL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>RBC Capital analyst Matthew Hedberg downgraded the rating for Rapid7, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) from Outperform to Sector Perform and lowered the price target from $50 to $40. Rapid7 shares gained 1.5% to close at $34.35 on Thursday. <a href="https://www.benzinga.com/quote/RPD/analyst-ratings">See how other analysts view this stock.</a></li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/5880b6f277f9dd00011b0aab/ravi-shanker">Morgan Stanley analyst Ravi Shanker downgraded FedEx Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) from Equal-Weight to Underweight and slashed the price target from $21</a>5 to $200. FedEx shares rose 0.7% to close at $300.39 on Thursday. <a href="https://www.benzinga.com/quote/FDX/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying PEP stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="526" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20085657/image-166-1024x526.png" alt="" class="wp-image-558335" style="width:668px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20085657/image-166-1024x526.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20085657/image-166-300x154.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20085657/image-166-768x395.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20085657/image-166.png 1306w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40952252/nvidia-tesla-rally-as-dow-s-p-500-surge-to-fresh-highs-after-fed-cuts-rates-fear-index-remains-in-g">Nvidia, Tesla Rally As Dow, S&amp;P 500 Surge To Fresh Highs After Fed Cuts Rates: Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

Downgrades

NTBL

This PepsiCo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

ACM Research, Inc. (ACMR) Q2 2024 Earnings Call Transcript

Analyst Charles Shi of Needham maintained a Buy rating on ACM Research (ACMR – Research Report), reducing the price target to $28.00. Charles Shi h...

ACM Research: Strong Buy on Surging Revenue and Shipment Growth Prospects

Roth MKM analyst Sujeeva De Silva maintained a Buy rating on ACM Research (ACMR – Research Report) today and set a price target of $30.00. The comp...

Roth MKM Remains a Buy on ACM Research (ACMR)

ACM Research: A Promising Semiconductor Growth Opportunity Outpacing Risks

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
In the market as in life, you get what you pay for. And that means stocks under $20 present a tricky narrative. Understandably, the topic gets plenty of traction. The biggest blue-chip enterprises tend to command three-digit price tags, if not greater. It just leaves regular folks on the outside looking in, especially if they don&rsquo;t have access to fractional equity capabilities.



To remedy this situation, some investors turn to cheap securities. However, the problem with this approach is that sometimes (many times), cheap valuations become even cheaper. When an organization prints gobs of red ink, there&rsquo;s usually a reason for it &mdash; and typically not a good one. Thus, it&rsquo;s more prudent to stick with quality names.



However, modestly priced equities have their place. Besides, with thousands upon thousands of opportunities available, it&rsquo;s practically impossible to cover all of them adequately. Some ideas simply fall through the cracks. These stocks under $20 deserve a closer inspection.



<h2>Innodata (INOD)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2023/05/ai-stocks1600-6-300x169.png" alt="Business growth concept. Businessman using AI, global business network, data analysis of financial and banking, AI stocks, business strategy, technology and data connection, security, networking. AI stocks to watch"><div>Source: Gmx Pixel / Shutterstock.com</div></div>A data engineering specialist, Innodata (NASDAQ:<a href="https://investorplace.com/stock-quotes/inod-stock-quote/">INOD</a>) also focuses on digital transformation and artificial intelligence. The company helps organizations extract utility out of their data for superior decision-making and efficiency. Further, its leveraging of AI should make INOD stock an intriguing idea for speculators.



One of the smaller enterprises, Innodata has enjoyed a strong performance this year. Nevertheless, it&rsquo;s prone to wild trading activity. Although INOD stock has witnessed volatility in recent sessions, its sales multiple is elevated at 4.8X. In contrast, in the prior year, the average price-to-sales ratio sat at 3.02X.



Still, patient speculators should keep INOD on their watchlist of stocks under $20. For fiscal 2024, analysts believe that <a href="https://finance.yahoo.com/quote/inod/analysis">sales may reach $121.57 million</a>. During the trailing 12 months (TTM), the company generated revenue of $94.44 million. In the following year, sales could hit just over $157 million.



Assuming a shares outstanding count of 28.75 million, INOD is trading around 2.8X projected 2025 sales. That makes it an even more tempting offer.



<h2>ReposiTrak (TRAK)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/07/supply-chain-300x169.jpg" alt="image of supply chain."><div>Source: Shutterstock</div></div>Focused on asset tracking and management solutions, ReposiTrak (NASDAQ:<a href="https://investorplace.com/stock-quotes/trak-stock-quote/">TRAK</a>) offers robust acumen in the Internet of Things (or IoT) and cloud-based solutions. With machines increasingly communicating with each other, ReposiTrak enjoys strong relevance. Also, the company&rsquo;s services can help foster operational efficiencies for its enterprise-level customers.



At the moment, TRAK stock carries a trailing-year sales multiple of 15.95X. That&rsquo;s quite high. During the first quarter of this year, the equity averaged 15.07X. Overall, in the past year, the stat came out to an average of 10.84X.



That said, the lone expert that&rsquo;s covering the company believes that fiscal 2024 sales may hit $20.34 million. If so, that would imply a 6.5% lift from last year&rsquo;s print of $19.1 million. In the following year, revenue <a href="https://finance.yahoo.com/quote/trak/analysis">could rise again to $23.02 million</a>. That would translate to a growth rate of 13.2% from projected 2024 sales.



Presently, ReposiTrak features a shares outstanding count of 18.22 million. Should this stat hold true, TRAK would trade at 13.4X next year&rsquo;s revenue. That&rsquo;s still hot but the trend is moving in the right direction. Thus, it&rsquo;s one of the stocks under $20 to watch.



<h2>Paymentus (PAY)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/04/digital-payment-300x169.jpg" alt="A concept image of mobile payment with a smart phone for a cup of coffee. affordable payment stocks"><div>Source: Shutterstock</div></div>A cloud-based bill payment technology, Paymentus (NYSE:<a href="https://investorplace.com/stock-quotes/pay-stock-quote/">PAY</a>) offers financial technology (fintech) services for businesses and institutions. It&rsquo;s an important player among stocks under $20 thanks to its ability to foster efficient and secure payment processing. Increasingly, transactions are conducted online and therefore demand for digital conveniences should only rise.



Despite the relevancies, PAY stock is trading at a relatively reasonable valuation. Currently, shares exchange hands at 3.77X sales. During Q1, this stat averaged a lofty 4.63X. In the previous quarter, the metric was 3.81X. Overall, in the past year, the multiple landed on average at 3.64X.



Moving forward, analysts anticipate significant business expansion. In fiscal 2024, sales could rise to $749 million, up 21.9% from last year&rsquo;s print of $614.49 million. In the following year, revenue might hit $889.27 million. Further, the <a href="https://finance.yahoo.com/quote/pay/analysis">high-side estimate calls for $907.22 million</a>.



Assuming a shares outstanding count of 21.91 million, PAY stock would be trading at 0.47X projected 2025 high-side sales. That might be too good of a deal for some speculators to pass up.



<h2>ACM Research (ACMR)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/02/acmr-stock-1-300x169.jpg" alt="a magnifying glass enlarges the ACM logo on a website"><div>Source: Pavel Kapysh / Shutterstock.com</div></div>A semiconductor specialist that specializes in process equipment, ACM Research (NASDAQ:<a href="https://investorplace.com/stock-quotes/acmr-stock-quote/">ACMR</a>) offers innovative solutions that help boost the efficiency and performance of semiconductor manufacturing. While it&rsquo;s not the most popular idea in terms of brand awareness, ACM offers critical &ldquo;background&rdquo; services.



Enticingly, ACMR stock trades around 1.84X revenue. In Q1, the sales multiple averaged 3.39X. Throughout the past year, the premium stood at 2.71X. Therefore, shares of the tech specialist can be had for a relative discount. It&rsquo;s also worth pointing out that ACMR trades at 1.46X book value, below the prior year average of 1.85X.



Looking out to year&rsquo;s end, covering experts believe that sales may soar to $710.11 million. If so, that would represent a lift of 27.3% from last year&rsquo;s haul of $557.72 million. And in fiscal 2025, revenue could reach $872.19 million, with a <a href="https://finance.yahoo.com/quote/acmr/analysis">high-side estimate of $984.8 million</a>.



Assuming a shares outstanding count of 56.99 million, ACMR is trading at 1.13X 2025 high-end sales. It makes a tempting case for stocks under $20.



<h2>McEwen Mining (MUX)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/gold1600c-300x169.jpg" alt="Gold nuggets on top of American paper money representing gold stocks"><div>Source: Shutterstock</div></div>Based in Canada, McEwen Mining (NYSE:<a href="https://investorplace.com/stock-quotes/mux-stock-quote/">MUX</a>) engages in the exploration, development and production of gold, silver and copper. Fundamentally, McEwen is attractive due to potential monetary policy pivots. If the Federal Reserve lowers the benchmark interest rate, that could be net positive for precious metals and core commodities. That should help MUX stock.



Right now, the mining firm features a price-to-sales ratio of 2.23. That&rsquo;s lower than the <a href="https://fullratio.com/ps-ratio-by-industry">gold sector&rsquo;s average multiple of 2.61X</a>. Further, in Q1 of this year, the metric stood at 2.82X. In the prior year, the stat averaged 2.68X. This implies that McEwen could grow into its prior valuation given the right catalyst. That could come in the form of interest rate cuts.



Notably, analysts believe that by the end of the current fiscal year, revenue could rise to $303.92 million. If so, that would imply a growth rate of 33.8% from last year&rsquo;s haul of $227.22 million. In the following year, <a href="https://finance.yahoo.com/quote/mux/analysis">sales could move up to $319.43 million</a>, with a high-side view of $524.02 million.



Thanks to the projected expansion of the business, MUX ranks among the stocks under $20.



<h2>Vaalco Energy (EGY)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/oil1600h-300x169.jpg" alt="miniature oil barrel and oil well figures on top of stack of money"><div>Source: Shutterstock</div></div>A hydrocarbon energy specialist, Vaalco Energy (NYSE:<a href="https://investorplace.com/stock-quotes/egy-stock-quote/">EGY</a>) engages in the exploration, development and production of crude oil and natural gas. Also known as the upstream component of the hydrocarbon value chain, Vaalco may enjoy increased demand due mainly to geopolitical flashpoints. Such conflicts may spill over and disrupt global oil inventories, which could cynically boost demand for EGY stock.



Right now, shares trade hands at 1.64X sales. To be sure, this stat comes at a premium relative to the prior year&rsquo;s average multiple of 1.07X. However, the upstream oil and gas sector features an average multiple of 1.93X. Therefore, EGY stock potentially has more room to grow.



Where the narrative gets a bit tricky is projections for this fiscal year. The consensus view calls for sales of $407.05 million. However, that&rsquo;s down almost 11% from last year&rsquo;s print of $455.07 million. Nevertheless, the high-side view calls for a <a href="https://finance.yahoo.com/quote/egy/analysis">top line of $494.8 million</a>. Further, the optimists are modeling for fiscal 2025 revenue to hit $567.05 million.



If anything, Vaalco is one of the best stocks under $20 if you want to hedge against an energy crisis.



<h2>Coursera (COUR)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2020/10/coursera-300x169.jpg" alt="The app page for Coursera is displayed on a smartphone screen with a website in the background."><div>Source: Postmodern Studio / Shutterstock.com</div></div>One of the riskiest ideas to consider among stocks under $20, Coursera (NYSE:<a href="https://investorplace.com/stock-quotes/cour-stock-quote/">COUR</a>) will be criticized for being a falling knife. Further, the rise of AI supposedly threatens the business model. However, I have a different view. The company specializes in providing an online learning platform. It&rsquo;s not just about acquiring new skills: Coursera offers professional certifications and college degree credits.



In other words, the company offers advantages that AI can&rsquo;t touch. That said, I&rsquo;m not na&iuml;ve to the heavy losses that COUR stock incurred since makings its public market debut. Nevertheless, it appears that since June, Coursera has been charting a series of higher lows. I don&rsquo;t want to jump ahead of myself but there could be a growth opportunity here.



Analysts are looking at revenue of just under $700 million by the end of this fiscal year. If so, that would be up 10.1% from last year&rsquo;s print of $635.76 million. Further, fiscal 2025 revenue could soar to $786.82 million, up 12.4% from projected 2024 sales.



With the right catalysts, COUR could fly. It&rsquo;s worth keeping on the radar.



On the date of publication, Josh Enomoto did not have (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<div>A former senior business analyst for Sony Electronics, Josh Enomoto has helped broker major contracts with Fortune Global 500 companies. Over the past several years, he has delivered unique, critical insights for the investment markets, as well as various other industries including legal, construction management, and healthcare. Tweet him at @EnomotoMedia.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget AI... THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul>
The post <a href="https://investorplace.com/2024/08/7-under-20-stock-picks-that-need-to-be-on-your-radar/">7 Under-$20 Stock Picks That Need to Be on Your Radar</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

7 Under-$20 Stock Picks That Need to Be on Your Radar

ACM Research: Maintaining Strong Buy Rating After Another Strong Quarter

Craig-Hallum analyst Christian Schwab maintained a Buy rating on ACM Research (ACMR – Research Report) today. The company's shares closed yesterday...

ACM Research (ACMR) Receives a Buy from Craig-Hallum

Which small-cap stocks look attractive currently? According to Wall Street analysts, the three stocks discussed below have earned a "Strong Buy" co...

3 Small-Cap Stocks with Big Potential, Say Analysts (8/30/24)

In a report released today, Sujeeva De Silva from Roth MKM maintained a Buy rating on ACM Research (ACMR – Research Report), with a price target of...

Roth MKM Keeps Their Buy Rating on ACM Research (ACMR)

ACM Research: A Niche Semiconductor Equipment Play With Significant Room To Grow

AMAT

COUR

INOD

LRCX

PLAY

TRAK

Press Releases

ACM Research Expands Advanced Packaging Portfolio with Introduction of Frame Wafer Cleaning Tool

Earnings

ACM Research Reports First Quarter 2024 Results

ACM Research to Participate in Upcoming Investor Conferences

ACM Research to Release Second Quarter 2024 Financial Results on August 7, 2024

ACM Research Appoints Howard Chen as General Counsel and Vice President of Corporate Strategy

ACM Research Enters Fan-out Panel Level Packaging Market with Introduction of Ultra C vac-p Flux Cleaning Tool for Chiplets

ACM Research Strengthens its Fan-Out Panel Level Packaging Portfolio with Launch of Ultra ECP ap-p Tool

ACM Research Reports Second Quarter 2024 Results

ACM Research Expands Fan-Out Panel-Level Packaging Portfolio with Launch of Ultra C bev-p Bevel Etching Tool

Contracts

ACM Research Receives Orders for Wafer-Level Packaging Tools from U.S. Customer and R&D Center

Axcelis Technologies, Inc. - Common Stock

Axcelis Technologies

Aehr Test System

Applied Mat

Amkor Tech

ASML Holding N.V. - New York Registry Shares

ASML Holding

Amtech Systems

Cohu

DAQO New Energy Corp. American Depositary Shares, each representing five ordinary shares

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

ACM Research

ACM Research (ACMR) Forecast

ACM Research (NASDAQ:ACMR) Stock, Quote.Headers.trade-ideas